Intravitreal triamcinolone for management of idiopathic juxtafoveolar telangiectasis
نویسندگان
چکیده
منابع مشابه
Neovascular membranes associated with idiopathic juxtafoveolar telangiectasis.
OBJECTIVE To report the visual outcome in patients with a neovascular membrane (NVM) associated with idiopathic juxtafoveolar telangiectasis (IJFT). METHODS We performed a retrospective, noncomparative analysis of 26 eyes of 16 patients with an NVM associated with bilateral IJFT (Gass classification group 2A). Eyes were divided into 2 groups: group WO (n = 11) included eyes with IJFT without ...
متن کاملOptical coherence tomography in group 2A idiopathic juxtafoveolar retinal telangiectasis.
OBJECTIVE To describe the changes observed with optical coherence tomography in group 2A idiopathic juxtafoveolar retinal telangiectasis. METHODS We retrospectively reviewed the medical records of 13 patients (25 eyes). All eyes underwent optical coherence tomography examination consisting of 6 radial scans, fundus color photography, and fluorescein angiography. We calculated retinal foveal a...
متن کاملIntravitreal Ranibizumab and Laser Photocoagulation in the Management of Idiopathic Juxtafoveolar Retinal Telangiectasia Type 1: A Case Report
BACKGROUND Idiopathic juxtafoveolar retinal telangiectasia (IJRT) type 1 represents an uncommon cause of congenital unilateral visual loss and it typically affects males. Decrease in visual acuity is caused by serous and lipid exudation into the fovea with cystoid macular edema. In some cases, spontaneous resolution may be observed, but when there is a progressive loss of visual acuity, laser p...
متن کامل[Intravitreal bevacizumab in the treatment of idiopathic juxtafoveal telangiectasis type I].
CLINICAL CASE We report a case of a 42 year-old male with a macular edema due to idiopathic juxtafoveal retinal telangiectasis type i, treated with 3 sequential injections of intravitreal bevacizumab (1.25 mg in 0.05 ml). Anatomical improvements were observed after one year of follow up. DISCUSSION There is currently no general consensus regarding the treatment of unilateral idiopathic juxtaf...
متن کاملIntravitreal Injection of Triamcinolone Acetonide
The introduction of pars plana vitrectomy in clinical ophthalmology by Robert Machemer and colleagues was a profound paradigm change which opened up new avenues for the treatment of ocular diseases, such as proliferative vitreoretinopathy, which up to that time had been incurable [79]. It was again Robert Machemer who together with Yasuo Tano, Gholam Peyman, Stephan Ryan and other researchers f...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Oman Journal of Ophthalmology
سال: 2010
ISSN: 0974-620X
DOI: 10.4103/0974-620x.60023